EBV drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| EBV | regulates | LCLs | — | 1 |
| Slc6a15 | expressed_in | EBV | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- The Immune Landscape of Cancer. (2018)
- Profiling tissue-resident T cell repertoires by RNA sequencing. (2015)
- Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
- Heritability and genomics of gene expression in peripheral blood. (2014)
- DNA methylation contributes to natural human variation. (2013)
- The Genotype-Tissue Expression (GTEx) project. (2013)
- Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. (2011)
- The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. (2008)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ebv | drug | 9 | 12 |
| ebv-immortalized cell lines | drug | — | — |
| ebv-transformed lymphoblastoid cell lines | drug | — | — |